
Faes Farma S.A (FAE) | Stock Overview & Key Data
Faes Farma S.A Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €19.40 on February 5, 2007
Explore how other Spanish stocks compare to their 52-week ranges: View ES Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Faes Farma S.A FAE | 1.31B Large-cap | -3.21% | -5.80% | -0.24% | 15.30% | 20.23% | 19.89% | 7.11% | 21.97% |
Laboratorios ROVI | 2.72B Large-cap | -2.03% | -3.37% | 3.41% | -4.32% | -17.03% | -32.16% | 1.36% | 86.38% |
Almirall S.A ALM | 2.20B Large-cap | -3.21% | -4.12% | 0.20% | 13.15% | 22.20% | 14.03% | 4.28% | 7.11% |
Laboratorio Reig RJF | 240.10M Mid-cap | 2.03% | 1.68% | 1.00% | 14.83% | 17.51% | 9.49% | 8.70% | -20.84% |
Labiana Health S.A LAB | 28.16M Small-cap | 4.32% | 15.57% | 19.14% | 33.10% | 31.29% | 22.58% | 6,233.33% | 1,051.52% |
Grifols, S.A GRF | 7.93B Large-cap | -2.06% | 22.50% | 57.28% | 54.08% | 35.84% | 46.52% | -6.61% | -47.55% |
Ownership & Short Interest
Faes Farma S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Faes Farma S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is FAE's 52-week high and low?
- In the last 52 weeks, Faes Farma S.A reached a high of €4.73 (on June 11, 2025) and a low of €3.27 (on March 17, 2025).
- What is the market cap and P/E ratio for FAE?
- Curious about Faes Farma S.A's size and valuation? Its market capitalization stands at 1.31B. When it comes to valuation, the P/E ratio (trailing twelve months) is 12.41, and the forward P/E (looking ahead) is 14.55.
- Does FAE pay dividends? If so, what's the yield?
- Yes, Faes Farma S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 6.64%, and the company has paid an average of €0.16 per share annually over the past 3 years.
- Who are Faes Farma S.A's main competitors or similar companies to consider before investing?
When looking at Faes Farma S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Laboratorios
ROVI2.72B Healthcare Drug Manufacturers - Specialty & Generic -32.16% 1.36% Almirall S.A
ALM2.20B Healthcare Drug Manufacturers - Specialty & Generic 14.03% 4.28% Laboratorio Reig
RJF240.10M Healthcare Drug Manufacturers - Specialty & Generic 9.49% 8.70% Labiana Health S.A
LAB28.16M Healthcare Drug Manufacturers - Specialty & Generic 22.58% 6,233.33% Grifols, S.A
GRF7.93B Healthcare Drug Manufacturers - General 46.52% -6.61% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Faes Farma S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Faes Farma S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 14.83%, the Debt to Equity ratio from the most recent quarter is 11.48, and its Gross Profit Margin stands at 69.26%.
- What is the recent revenue and earnings growth for FAE?
- Looking at Faes Farma S.A's growth, its revenue over the trailing twelve months (TTM) was €544M. Compared to the same quarter last year (YoY), quarterly revenue grew by 14.70%, and quarterly earnings saw a YoY growth of -14.10%.
- How much of FAE stock is held by insiders and institutions?
- Wondering who owns Faes Farma S.A stock? Company insiders (like executives and directors) hold about 13.34% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 19.57%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.